Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 209.93B | 210.84B | 236.49B | 226.17B | 167.79B | 289.28B |
Gross Profit | 24.15B | 26.03B | 29.61B | 27.26B | 20.25B | 16.22B |
EBITDA | 10.25B | 10.15B | 9.98B | 10.60B | 4.91B | -1.39B |
Net Income | 4.47B | 4.27B | 3.40B | 5.20B | 2.44B | -2.13B |
Balance Sheet | ||||||
Total Assets | 137.04B | 144.76B | 174.12B | 176.00B | 148.18B | 127.01B |
Cash, Cash Equivalents and Short-Term Investments | 20.61B | 24.25B | 23.82B | 21.25B | 25.25B | 26.87B |
Total Debt | 45.88B | 50.53B | 64.71B | 74.64B | 53.93B | 47.47B |
Total Liabilities | 77.53B | 84.26B | 117.69B | 122.92B | 100.61B | 81.97B |
Stockholders Equity | 53.81B | 54.52B | 50.70B | 47.75B | 42.71B | 40.01B |
Cash Flow | ||||||
Free Cash Flow | 18.06B | 17.18B | 21.52B | -19.25B | -3.69B | 14.66B |
Operating Cash Flow | 19.85B | 18.62B | 22.69B | -18.98B | -2.95B | 15.21B |
Investing Cash Flow | -2.74B | -2.15B | -1.42B | -326.00M | 145.00M | -790.00M |
Financing Cash Flow | -16.84B | -16.41B | -20.05B | 14.07B | 391.00M | -8.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥31.60B | 7.08 | 5.46% | -7.46% | 7.37% | ||
61 Neutral | $35.55B | 8.91 | -10.55% | 1.87% | 8.47% | -8.26% | |
― | $180.82M | 57.86 | 1.11% | ― | ― | ― | |
78 Outperform | ¥41.48B | 19.12 | 4.20% | -10.70% | -50.96% | ||
77 Outperform | ¥20.16B | 21.54 | 4.55% | -3.90% | -44.26% | ||
75 Outperform | ¥14.71B | 10.17 | 2.80% | -5.42% | -29.21% | ||
67 Neutral | ¥21.67B | 5.20 | 3.92% | 32.77% | 280.02% |